3.30
price down icon5.17%   -0.18
 
loading
Chromadex Corp stock is currently priced at $3.30, with a 24-hour trading volume of 256.29K. It has seen a -5.17% decreased in the last 24 hours and a -16.88% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $3.54 pivot point. If it approaches the $3.16 support level, significant changes may occur.
Previous Close:
$3.48
Open:
$3.5
24h Volume:
256.29K
Market Cap:
$249.28M
Revenue:
$83.57M
Net Income/Loss:
$-4.94M
P/E Ratio:
-36.67
EPS:
-0.09
Net Cash Flow:
$6.97M
1W Performance:
-3.51%
1M Performance:
-16.88%
6M Performance:
+130.77%
1Y Performance:
+112.90%
1D Range:
Value
$3.25
$3.54
52W Range:
Value
$1.25
$4.65

Chromadex Corp Stock (CDXC) Company Profile

Name
Name
Chromadex Corp
Name
Phone
949-419-0288
Name
Address
10005 Muirlands Boulevard, Suite G, Irvine
Name
Employee
71
Name
Twitter
@Chromadex
Name
Next Earnings Date
2024-05-08
Name
Latest SEC Filings
Name
CDXC's Discussions on Twitter

Chromadex Corp Stock (CDXC) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-16-22 Downgrade Oppenheimer Outperform → Perform
Aug-11-22 Downgrade B. Riley Securities Buy → Neutral
Mar-08-22 Initiated ROTH Capital Buy
Oct-16-19 Initiated Oppenheimer Outperform
Feb-14-19 Initiated B. Riley FBR Buy
Nov-27-17 Resumed H.C. Wainwright Buy
Sep-25-17 Initiated Ladenburg Thalmann Buy
Jan-03-17 Initiated Rodman & Renshaw Buy
View All

Chromadex Corp Stock (CDXC) Financials Data

Chromadex Corp (CDXC) Revenue 2024

CDXC reported a revenue (TTM) of $83.57 million for the quarter ending December 31, 2023, a +15.99% rise year-over-year.
loading

Chromadex Corp (CDXC) Net Income 2024

CDXC net income (TTM) was -$4.94 million for the quarter ending December 31, 2023, a +70.15% increase year-over-year.
loading

Chromadex Corp (CDXC) Cash Flow 2024

CDXC recorded a free cash flow (TTM) of $6.97 million for the quarter ending December 31, 2023, a +145.16% increase year-over-year.
loading

Chromadex Corp (CDXC) Earnings per Share 2024

CDXC earnings per share (TTM) was -$0.07 for the quarter ending December 31, 2023, a +69.57% growth year-over-year.
loading

Chromadex Corp Stock (CDXC) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Jaksch Frank L Jr
Director
Jun 12 '23
Buy
1.69
7,000
11,830
231,339
Fried Robert N
Chief Executive Officer
May 31 '23
Buy
1.42
7,000
9,940
95,001
Rubin Steven D
Director
May 25 '23
Buy
1.46
7,000
10,220
7,000
ChromaDex Corporation operates as a nutraceutical company. The company offers research and quality control products and services to dietary supplements, food, beverages, cosmetic, and pharmaceutical industries; Nicotinamide riboside (NIAGEN), a novel form of vitamin B3 for enhancing nicotinamide adenine dinucleotide(NAD) level used for healthy aging; Pterostilbene (pTeroPure), a polyphenol and antioxidant used in health related fields; and Immulina, a spirulina extract and compound, which is used for improving human immune function, as well as developing Pterostilbene and caffeine co-crystal ingredients, and anthocyanins ingredients. It also provides reference standards, materials, and kits to conduct quality control of raw materials and consumer products; and fine chemicals and phytochemicals for research and new product development applications. In addition, the company offers a range of consulting services, including regulatory support, product development, risk management, and litigation support. Further, it assists customers in creating processes for manufacturing natural products using green chemistry, as well as developing phytochemical libraries. The company markets and sells its products directly in the United States and Canada; and through international distributors. ChromaDex Corporation has a strategic partnership for healthy aging research with the Jiangxi Provincial Government, the People's Republic of China. ChromaDex Corporation is based in Irvine, California.
$77.56
price up icon 0.77%
$149.40
price down icon 1.20%
$29.98
price up icon 1.11%
$172.85
price up icon 1.06%
$365.81
price down icon 2.87%
$90.61
price down icon 2.55%
Cap:     |  Volume (24h):